✦ LIBER ✦

Response to Xie and Yi: Ankylosing spondylitis: a β2m-deposition disease?

✍ Scribed by Barbara Uchanska-Ziegler; Andreas Ziegler

Book ID: 117787365
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 69 KB
Volume: 24
Category: Article
ISSN: 1471-4906
DOI: 10.1016/s1471-4906(03)00078-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ankylosing spondylitis: a β2m–deposition

Ankylosing spondylitis: a β2m–deposition disease?

✍ Barbara Uchanska-Ziegler; Andreas Ziegler 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 106 KB

Antibody responses to gut bacteria in an

Antibody responses to gut bacteria in ankylosing spondylitis, rheumatoid arthritis, Crohn's disease and ulcerative colitis

✍ H. Tiwana; C. Wilson; R. S. Walmsley; A. J. Wakefield; M. S. N. Smith; N. L. Cox 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 115 KB

A locus on chromosome 9p predisposes to

A locus on chromosome 9p predisposes to a specific disease manifestation, acute anterior uveitis, in ankylosing spondylitis, a genetically complex, multisystem, inflammatory disease

✍ Tammy M. Martin; Ge Zhang; Jingchun Luo; Li Jin; Trudy M. Doyle; Barbara M. Rajs 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB 👁 2 views

## Abstract ## Objective Uveitis or intraocular inflammation is a major cause of visual loss. Acute anterior uveitis (AAU) affects ∼40% of patients with ankylosing spondylitis (AS) but also affects patients with no evidence of spondylarthritis. We sought to determine whether a unique genetic regio

Different response to rituximab in tumor

Different response to rituximab in tumor necrosis factor blocker–naive patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: A twenty-four–week clinical trial

✍ I.-H. Song; F. Heldmann; M. Rudwaleit; J. Listing; H. Appel; J. Braun; J. Sieper 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB 👁 2 views

Biologic response to subcutaneous and in

Biologic response to subcutaneous and intranasal therapy with desmopressin in a large Amish kindred with Type 2M von Willebrand disease

✍ A. SHARTHKUMAR; A. GREIST; J. DI PAOLA; J. WINAY; C. ROBERSON; M. HEIMAN; S. HER 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB

Identification of glutamine and lysine r

Identification of glutamine and lysine residues in Alzheimer amyloid βA4 peptide responsible for transglutaminase-catalysed homopolymerization and cross-linking to α2M receptor

✍ Lone K. Rasmussen; Esben S. Sørensen; Torben E. Petersen; Jørgen Gliemann; Poul 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 646 KB